Zobrazeno 1 - 10
of 30
pro vyhledávání: '"van Giezen Jj"'
Autor:
van Giezen Jj, Håkan Emanuelsson, Li-Ming Gan, Sven Nylander, Jenny Jonasson, Gunnar Brandrup-Wognsen, Ann Wittfeldt
Publikováno v:
Journal of the American College of Cardiology. 62:647
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08866058b5f04e4d1e951de1b0e4fea2
https://doi.org/10.1016/j.jacc.2013.05.039
https://doi.org/10.1016/j.jacc.2013.05.039
Publikováno v:
Journal of Cardiovascular Pharmacology & Therapeutics; Jun2012, Vol. 17 Issue 2, p164-172, 9p
Autor:
Baaten CC; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., Veenstra LF; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., Wetzels R; Central Diagnostic Laboratory, Maastricht University Medical Centre, The Netherlands., van Geffen JP; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., Swieringa F; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., de Witt SM; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., Henskens YM; Central Diagnostic Laboratory, Maastricht University Medical Centre, The Netherlands., Crijns H; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., Nylander S; AstraZeneca R&D, Mölndal, Sweden., van Giezen JJ; AstraZeneca R&D, Mölndal, Sweden., Heemskerk JW; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands., van der Meijden PE; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, The Netherlands p.vandermeijden@maastrichtuniversity.nl.
Publikováno v:
Haematologica [Haematologica] 2015 Sep; Vol. 100 (9), pp. 1131-8. Date of Electronic Publication: 2015 Jun 25.
Autor:
Giordanetto F; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden. Electronic address: fgiordanetto@tarosdiscovery.com., Bach P; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Zetterberg F; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Antonsson T; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Bylund R; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Johansson J; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Sellén M; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Brown D; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Hideståhl L; Medicinal Chemistry, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Berntsson P; Bioscience, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Hovdal D; DMPK AstraZeneca R&D, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Zachrisson H; Bioscience, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Björkman JA; Bioscience, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., van Giezen JJ; Bioscience, CVMD iMed, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2014 Jul 01; Vol. 24 (13), pp. 2963-8. Date of Electronic Publication: 2014 Apr 12.
Autor:
Armstrong D; 1Safety Pharmacology, Global Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom., Summers C, Ewart L, Nylander S, Sidaway JE, van Giezen JJ
Publikováno v:
Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2014 Mar; Vol. 19 (2), pp. 209-19. Date of Electronic Publication: 2014 Jan 10.
Autor:
Bach P; CVGI Medicinal Chemistry, ‡CVGI Bioscience, and §CVGI iMED Project Management, AstraZeneca R&D Mölndal , Pepparedsleden 1, S-43183 Mölndal, Sweden., Antonsson T, Bylund R, Björkman JA, Österlund K, Giordanetto F, van Giezen JJ, Andersen SM, Zachrisson H, Zetterberg F
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2013 Sep 12; Vol. 56 (17), pp. 7015-24. Date of Electronic Publication: 2013 Aug 29.
Autor:
Gan LM, Wittfeldt A, Brandrup-Wognsen G, van Giezen JJ, Jonasson J, Nylander S, Emanuelsson H
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2013 Aug 13; Vol. 62 (7), pp. 647. Date of Electronic Publication: 2013 Jun 07.
Autor:
Bach P; Department of Medicinal Chemistry, AstraZeneca R&D Mölndal, Pepparedsleden 1, S-43183 Mölndal, Sweden. bach@chalmers.se, Boström J, Brickmann K, van Giezen JJ, Groneberg RD, Harvey DM, O'Sullivan M, Zetterberg F
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2013 Jul; Vol. 65, pp. 360-75. Date of Electronic Publication: 2013 May 15.
Autor:
Wittfeldt A; Department of Clinical and Molecular Medicine, Institution of Medicine, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden., Emanuelsson H, Brandrup-Wognsen G, van Giezen JJ, Jonasson J, Nylander S, Gan LM
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2013 Feb 19; Vol. 61 (7), pp. 723-7. Date of Electronic Publication: 2013 Jan 09.
Autor:
Ravnefjord A; Department of Bioscience, AstraZeneca R&D Mölndal, Sweden. Anna.Ravnefjord@astrazeneca.com, Weilitz J, Emanuelsson BM, van Giezen JJ
Publikováno v:
Thrombosis research [Thromb Res] 2012 Oct; Vol. 130 (4), pp. 622-8. Date of Electronic Publication: 2012 Aug 19.